Ishii Itsuko
Division of Pharmacy, Chiba University Hospital.
Yakugaku Zasshi. 2022;142(6):601-609. doi: 10.1248/yakushi.21-00234-1.
The fight against coronavirus disease 2019 (COVID-19) in Japan began after January 2020. In order for the country to resume an active social life as a society, it is necessary to prevent an increase in the number of newly infected people with severe acute respiratory syndrome corona virus 2 (SARS-CoV-2), and to prevent aggravation and/or death after infection. Although several therapeutic agents have been developed to treat COVID-19 after infection, vaccination with SARS-CoV-2 is the most effective in controlling or even ending the COVID-19 pandemic in Japan. The Ministry of Health, Labour and Welfare has convened a council to publish the collected data on COVID-19 and to proceed with discussions for promoting safe and effective vaccination. However, no matter how we release to the public the scientific basis of our findings and proposed methods of prevention and treatment, there remain cases where false opinions have spread, and vaccinations are refused accordingly. This paper traces the course of the work of this council, and considers current challenges in communicating COVID-19 information to the public based on scientific evidence.
日本针对2019冠状病毒病(COVID-19)的抗疫工作于2020年1月之后展开。为了让日本社会恢复积极的社交生活,有必要防止严重急性呼吸综合征冠状病毒2(SARS-CoV-2)新增感染人数增加,并防止感染后病情加重和/或死亡。尽管已经研发出了几种治疗感染后COVID-19的治疗药物,但接种SARS-CoV-2疫苗对于控制乃至结束日本的COVID-19大流行最为有效。厚生劳动省召集了一个委员会,以公布收集到的COVID-19数据,并继续进行促进安全有效疫苗接种的讨论。然而,无论我们如何向公众公布研究结果的科学依据以及提议的预防和治疗方法,仍然存在错误观点传播的情况,相应地有人拒绝接种疫苗。本文追溯了该委员会的工作历程,并探讨了基于科学证据向公众传达COVID-19信息方面当前面临的挑战。